Outcome measures
| Value | |
|---|---|
| Platelet function test | |
| Yes | 89 (100%) |
| No | 0 (0%) |
| Clopidogrel responder | |
| Yes | 66 (74.2%) |
| No | 23 (25.8%) |
| Angiographic outcome | |
| Imaging follow-up | |
| Median (range) (mo) | 27 (9–60) |
| Data availability | 89/92 (96.7%) |
| Long-term imaging follow-up rate with aneurysm persistent at 6 mo | 41/43 (95.3%) |
| Occlusion rate at 6 mo | |
| Complete (100%) | 62 (59.0%) |
| Near-complete (90%–99%) | 20 (19.0%) |
| Partial (<90%) | 23 (22.0%) |
| Occlusion rate at last follow-up | |
| Complete (100%) | 74 (70.5%) |
| Near-complete (90%–99%) | 17 (16.2%) |
| Partial (<90%) | 14 (13.3%) |
| Adjunctive coil | 35 (33.3%) |
| Retreatment | 5 (5.5%) |
| Clinical outcome | |
| Posttreatment mRS | |
| 0–2 | 84 (94.4%) |
| 3–5 | 5 (5.6%) |
| 6 (death) | 0 (0%) |
| mRS at last follow-up | |
| Improved | 16 (18.0%) |
| No change | 73 (82.0%) |
| Worsened | 0 (0%) |
| Neurologic complications | |
| Thromboembolic | 40 (44.0%) |
| Symptomatic | 6 (6.6%) |
| Hemorrhagic | 3 (3.3%) |
| Symptomatic | 0 (0%) |
| Symptomatic cranial nerve compression | 1 (1.1%) |
| Long-term outcome | |
| Rupture of aneurysm at follow-up | 0 (0%) |
| Compression improved at follow-up | 10 (37.0%) |
| Permanent neurologic complication | 0 (0%) |
| Permanent neurologic death | 0 (0%) |